Hero of 3rd Annual Clinical Quality Oversight, May 21-23, 2024 | Hybrid Event, The Notary, Philadelphia

2024 CQO Conference Co-Chairs

Sharon Reinhard

Head of Commercial and R&D Quality

Logo of AVEO Oncology

Michael Torok, Ph.D.

Vice President, Global Head of Quality Assurance Programs

Logo of Genentech

Momentum’s Clinical Quality Oversight Conference is the annual gathering for clinical quality and operations professionals to collaborate, share and engage on critical topics related to the optimization of clinical quality through effective oversight of all stakeholders. Oversight is a key focus area of the recently released draft of ICH E6(R3) making now the time to conduct a gap analysis to know where and how to prioritize your efforts to achieve compliance

Join this interactive event of like-minded quality-first clinical professionals to explore effective strategies to ensure clinical risk is being mitigated and managed across all stakeholders.

Kristen Hunter
VP, Content and Experience

In-Person Experience


Access to All Offered Content and Networking Opportunities + Option to Add-On Pre-Conference Workshops

Virtual Experience


Select Main Conference Sessions Accessible Virtually ○ NO ACCESS to Roundtable Discussions, Pre-Conference Workshops, and Sessions not Indicated as Accessible Virtually in the Agenda

2023 Testimonials


Audience Stats and Demographics

(Averages from CQO 2022 and 2023)

  • Total Attendees 100% 100%
  • Attend In-Person 65% 65%
  • Audience Represents Pharma/Biotech/Device Companies 63% 63%
  • Trial Sponsors in Attendance Identify as Decision-Makers 53% 53%

Breakdown of Company Sizes

Main Area of Responsibility

Gold Sponsor

Logo of InSeption Group

Media Partner

Logo of Clinical Trial Vanguard


Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

Top Reasons to Attend

Learn the new oversight recommendations, as outlined in the ICH E6(R3) draft and what actions you should be taking now to ensure compliance 

Optimize clinical vendor selection and qualification criteria based upon the critical to quality factors of the study 

Online effective documentation of oversight practices and where that documentation should live 

Leverage auditing as an effective oversight tool and derive actionable insight to improve operations and performance

Develop an effective communication and escalation plan when series issues are identified and build quality into the relationship from the onset


This event is developed for professionals from pharmaceutical, biotechnology and medical device companies, CROs, clinical service and technology providers as well as those professionals from sites who have responsibilities in any the following areas:

  • Quality Management/ Clinical Quality Management
  • Clinical Quality Assurance/ QA/ CQA
  • Clinical Quality Control/ QC/ CQC
  • Quality Operations/ Quality Systems/ Quality Processes
  • Clinical Operations/ Management/ Research/ Development
  • Compliance/ Clinical Compliance/ Regulatory Compliance
  • Auditing
  • Inspection/ Inspection Readiness
  • Clinical Outsourcing/ Vendor Oversight and Management/ Strategic Partnerships/ Third-Party Management and Oversight
  • Clinical Risk/ Quality Risk/ Risk Assessment/ Risk Management
  • Site Monitoring/ Site Management/ Study Management/ Trial Management
  • Good Clinical Practice/ GCP
  • Clinical Data
  • Regulatory Affairs